IFS
IDXX icon

Intelligent Financial Strategies’s Idexx Laboratories IDXX Stock Holding History

Intelligent Financial Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Hold
50
– – 0.01% 51
2026
Q1 		$28.1K Hold
50
– – 0.01% 52
2025
Q4 		$33.8K Hold
50
– – 0.02% 58
2025
Q3 		$31.9K Hold
50
– – 0.02% 58
2025
Q2 		$26.8K Hold
50
– – 0.01% 69
2025
Q1 		$21K Hold
50
– – 0.01% 73
2024
Q4 		$20.7K Hold
50
– – 0.01% 72
2024
Q3 		$25.3K Hold
50
– – 0.01% 74
2024
Q2 		$24.4K Hold
50
– – 0.02% 71
2024
Q1 		$27K Hold
50
– – 0.02% 76
2023
Q4 		$27.8K Sell
50
-100
-67% -$46.9K 0.02% 65
2023
Q3 		$65.6K Hold
150
– – 0.05% 54
2023
Q2 		$75.3K Hold
150
– – 0.06% 53
2023
Q1 		$75K Hold
150
– – 0.06% 56
2022
Q4 		$61.2K Buy
150
+50
+50% +$19.4K 0.05% 59
2022
Q3 		$33K Hold
100
– – 0.03% 68
2022
Q2 		$35K Sell
100
-404
-80% -$165K 0.04% 69
2022
Q1 		$276K Sell
504
-91
-15% -$47.9K 0.27% 41
2021
Q4 		$392K Buy
+595
New +$374K 0.35% 40

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Intelligent Financial Strategies's IDXX Position: Q2 2026 in Review

Intelligent Financial Strategies held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 50 shares worth $26.3K. The position accounts for 0.01% of the portfolio, ranked #51.

Intelligent Financial Strategies first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $392K in Q4 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Intelligent Financial Strategies held 50 shares of Idexx Laboratories worth $26.3K as of Q2 2026.
  • Intelligent Financial Strategies left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.01% of Intelligent Financial Strategies's portfolio in Q2 2026, its #51 holding.
  • Intelligent Financial Strategies first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Intelligent Financial Strategies's Idexx Laboratories position peaked at $392K in Q4 2021.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Intelligent Financial Strategies's 13F filing for Q2 2026, filed 24 Jul 2026.